Appili Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
November 14, 2023 at 04:02 pm EST
Appili Therapeutics Inc. reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was CAD 0.337313 million. Net loss was CAD 0.976555 million compared to CAD 1.64 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the six months, sales was CAD 0.337313 million. Net loss was CAD 2.53 million compared to CAD 3.96 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.04 a year ago.